Home › Small Cell Lung Cancer › Wisconsin
Small Cell Lung Cancer clinical trials in Wisconsin
11 studies for Small Cell Lung Cancer are looking for participants at sites in Wisconsin.
Cities in Wisconsin
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- UW Health Carbone Cancer Center, Madison
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07488676DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- University of Wisconsin, Madison
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07472517A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- Medical College of Wisconsin ( Site 1112), Milwaukee
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT06780137The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- University of Wisconsin /ID# 279909, Madison
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- Gundersen, La Crosse
- Aspirus Cancer Center Wausau, Wausau
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07057791A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Marshfield Medical Center, Marshfield
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06095505A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- University of Wisconsin- Madison, Madison
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT06203210Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
- University of Wisconsin, Madison
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 8, 2026 · NCT04919382Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Duluth Clinic Ashland, Ashland
- Gundersen Lutheran Medical Center, La Crosse
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT06769126From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.